Michael G. Jr. Hanna
#167,208
Most Influential Person Now
Michael G. Jr. Hanna's AcademicInfluence.com Rankings
Michael G. Jr. Hannaengineering Degrees
Engineering
#7443
World Rank
#8818
Historical Rank
Biomedical Engineering
#752
World Rank
#764
Historical Rank
Michael G. Jr. Hannaphilosophy Degrees
Philosophy
#9896
World Rank
#13520
Historical Rank
Logic
#6848
World Rank
#8403
Historical Rank
Download Badge
Engineering Philosophy
Michael G. Jr. Hanna's Degrees
- Doctorate Medicine Stanford University
Why Is Michael G. Jr. Hanna Influential?
(Suggest an Edit or Addition)Michael G. Jr. Hanna's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial (1999) (493)
- Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis. (1972) (361)
- Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. (2000) (257)
- Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial. (1993) (251)
- Macrophage Activation (1984) (158)
- Prospectively randomized trial of adjuvant active‐specific immunotherapy for human colorectal cancer (1985) (156)
- Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis. (1972) (148)
- Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise. (2001) (133)
- Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits. (2005) (125)
- Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells. (1976) (125)
- The ultrastructure of antigen localization and viruslike particles in mouse spleen germinal centers. (1968) (121)
- Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients. (1985) (120)
- AUTOGENOUS IMMUNITY TO ENDOGENOUS RNA TUMOR VIRUS : RADIOIMMUNE PRECIPITATION ASSAY OF MOUSE SERUM ANTIBODY LEVELS (1973) (119)
- Localization of 125I-labeled antigen in germinal centers of mouse spleen: histologic and ultrastructural autoradiographic studies of the secondary immune reaction. (1968) (118)
- Preparation of immunotherapeutic autologous tumor cell vaccines from solid tumors. (1979) (106)
- Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with an autologous tumor cell: Bacillus Calmette-Guérin vaccine. (1984) (106)
- Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine. (1978) (82)
- AUTOGENOUS IMMUNITY TO ENDOGENOUS RNA TUMOR VIRUS (1974) (81)
- Specific immunotherapy of established visceral micrometastases by BCG‐tumor cell vaccine alone or as an adjunct to surgery (1978) (80)
- Lymphatic Tissue and Germinal Centers in Immune Response (1969) (77)
- Guinea pig line 10 hepatocarcinoma model: characterization of monoclonal antibody and in vivo effect of unconjugated antibody and antibody conjugated to diphtheria toxin A chain. (1983) (76)
- Ultrastructural studies of histiocyte-tumor cell interactions during tumor regression after intralesional injection of Mycobacterium bovis. (1973) (73)
- Polypeptides of mammalian oncornaviruses. III. Localization of p 15 and reactivity with natural antibody. (1975) (72)
- Regression of established intradermal tumors and lymph node metastases in guinea pigs after systemic transfer of immune lymphoid cells. (1977) (68)
- Effect of calcium chromate dust, influenza virus, and 100 R whole-body x radiation on lung tumor incidence in mice. (1971) (68)
- Leukoregulin, a direct-acting anticancer immunological hormone that is distinct from lymphotoxin and interferon. (1985) (65)
- Histopathology of tumor regression after intralesional injection of Mycobacterium bovis., 2. Comparative effects of vaccinia virus, oxazolone, and turpentine. (1972) (61)
- Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells. (1974) (61)
- Histopathology of Tumor Regression After Intralesional Injection of Mycobacferium bovis. IV. Development of Immunity to Tumor Cells and BCG (1973) (53)
- AN AUTORADIOGRAPHIC STUDY OF THE GERMINAL CENTER IN SPLEEN WHITE PULP DURING EARLY INTERVALS OF THE IMMUNE RESPONSE. (1964) (53)
- Effect of Antigen Dose on Lymphatic Tissue Germinal Center Changes.∗ (1966) (52)
- Immunotherapy of metastases enhances subsequent chemotherapy. (1982) (50)
- Current status of cancer immunodetection with radiolabeled human monoclonal antibodies. (1993) (50)
- Changes induced by lactic dehydrogenase virus in thymus and thymus-dependent areas of lymphatic tissue. (1972) (49)
- Localization of 111In- and 125I-labeled monoclonal antibody in guinea pigs bearing line 10 hepatocarcinoma tumors. (1983) (49)
- GERMINAL CENTER CHANGES AND PLASMA CELL REACTION DURING THE PRIMARY IMMUNE RESPONSE. (1965) (48)
- Autogenous immunity to endogenous RNA tumor virus antigens in mice with a low natural incidence of lymphoma. (1972) (48)
- Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumors. (1988) (46)
- Serum Alpha Globulin Fraction: Survival-and-Recovery Effect in Irradiated Mice (1967) (45)
- Histoproliferative effect of Rauscher leukemia virus on lymphatic tissue: histological and ultrastructural studies of germinal centers and their relation to leukemogenesis. (1970) (42)
- Depletion of mitochondrial DNA by ddC in untransformed human cell lines (1997) (41)
- Suppressive effect of immunization with mouse fetal antigens on growth of cells infected with Rauscher leukemia virus and plasma-cell tumors. (1971) (39)
- Active specific immunotherapy of established micrometastasis: effect of cryopreservation procedures on tumor cell immunogenicity in guinea pigs. (1980) (38)
- Guinea pig line 10 hepatocarcinoma model for monoclonal antibody serotherapy: in vivo localization of a monoclonal antibody in normal and malignant tissues. (1983) (37)
- Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer. (1985) (34)
- ELECTRON MICROSCOPIC AUTORADIOGRAPHY OF GERMINAL CENTER CELLS IN MOUSE SPLEEN (1965) (34)
- A diagnostic-prognostic test for bladder cancer using a monoclonal antibody-based enzyme-linked immunoassay for detection of urinary fibrin(ogen) degradation products. (1984) (32)
- Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. II. Response in C57BL/6 mice. (1976) (32)
- Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer. (1983) (31)
- Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG. (1974) (31)
- Natural immunity to endogenous oncornaviruses in mice. (1977) (30)
- Reduced Immune Potential of Aged Mice (1967) (30)
- Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies. (1998) (29)
- A new fiducial alignment system to overlay abdominal computed tomography or magnetic resonance anatomical images with radiolabeled antibody single‐photon emission computed tomographic scans (1994) (29)
- Localization of Antigen and Immune Complexes in Lymphatic Tissue, with Special Reference to Germinal Centers (1971) (28)
- Autogenous Immunity to Endogenous RNA Tumor Virus: Differential Reactivities of Immunoglobulins M and G to Virus Envelope Antigens (1974) (28)
- AUTOGENOUS IMMUNITY TO ENDOGENOUS RNA TUMOR VIRUS (1973) (28)
- Autogenous immunity to endogenous RNA tumor virus: chronic humoral immune response to virus envelope antigens in B6C3F1 mice. (1974) (28)
- Therapy of spontaneous metastases with an autologous tumor vaccine in a guinea pig model. (1981) (27)
- Efficacy of intralesional bcg therapy in guinea pigs with disseminated tumor (1975) (27)
- Mechanisms of macrophage-mediated tumor cytolysis. (1982) (26)
- Biology of cancer therapy: some new insights into adjuvant treatment of metastatic solid tumors. (1983) (25)
- Decreasing immune competence and development of reticulum cell sarcomas in lymphatic tissue of aged mice. (1971) (25)
- Expression of class II major histocompatibility complex molecules correlates with human colon tumor vaccine efficacy. (1992) (24)
- Morphological and functional aspects of active specific immunotherapy of established pulmonary metastases in guinea pigs. (1981) (24)
- MANGANESE deficiency. (2022) (24)
- REQUIREMENT FOR CONTINUOUS ANTIGENIC STIMULATION IN THE DEVELOPMENT AND DIFFERENTIATION OF ANTIBODY-FORMING CELLS (1969) (24)
- Localization of 125-I-labelled antigen in germinal centres of mouse spleen: effects of competitive injection of specific or non-cross-reacting antigen. (1968) (23)
- Morphologic changes in spleen lymphatic tissue during antibody production. (1966) (21)
- Tumor activity confirmation and isodose curve display for patients receiving iodine‐131‐labeled 16.88 human monoclonal antibody (1994) (21)
- Delayed-type hypersensitivity reactions to tumor-associated antigens in colon carcinoma patients immunized with an autologous tumor cell/Bacillus Calmette-Guérin vaccine. (1993) (21)
- Active immunotherapy in colorectal cancer. (1989) (21)
- Immunotherapy with autologous tumor cell vaccines for treatment of occult disease in early stage colon cancer. (2012) (20)
- Visualization of a guinea pig T lymphocyte surface component cross-reactive with immunoglobulin. (1978) (20)
- Human immune response to active immunization with Rauscher leukemia virus. II. Humoral immunity. (1974) (19)
- Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response. (1981) (19)
- Active specific immunotherapy of residual micrometastasis (1979) (18)
- Active specific immunotherapy of established micrometastases with BCG plus tumor cell vaccines: Effective treatment of BCG side effects with isoniazid (1982) (18)
- A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma. (1996) (18)
- Assessment of reactivities of natural antibodies to endogenous RNA tumor virus envelope antigens and virus-induced cell surface antigens. (1975) (18)
- Immune suppression and carcinogenesis in hamsters during topical application of 7,12-dimethylbenz(a)anthracene. (1972) (18)
- Evaluation of BCG administered by scarification for immunotherapy of metastatic hepatocarcinoma in the guinea pig. (1976) (18)
- Identification of colon‐tumor‐associated antigens by T‐cell lines derived from tumor‐infiltrating lymphocytes and peripheral‐blood lymphocytes from patients immunized with an autologous tumor‐cell/bacillus calmette‐Guérin vaccine (1993) (17)
- The Relation of Antigen and Virus Localization to the Development and Growth of Lymphoid Germinal Centers (1969) (17)
- Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. III. Influence on endogenous MuLV-mediated pathogenesis. (1976) (16)
- Host response to tumor-associated fetal antigens. (1974) (16)
- Fetal antigens in human leukemia. (1976) (16)
- Radiosensitivity of the Antigen-Trapping Mechanism and its Relation to the Suppression of Immune Response (1969) (15)
- Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system. (1993) (15)
- Immunological Cross-reactivity of Antigens common to Tumour and Foetal Cells (1972) (15)
- Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. II. Influence of the local inflammatory response on immune reactivity. (1981) (15)
- Further studies on the effect of serum alpha macroglobulin on regeneration of hemopoietic tissue after x-irradiation. (1968) (15)
- Contemporary Topics in Immunobiology (1978) (14)
- A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs. (1976) (14)
- Histoproliferative Effect of Rauscher Leukemia Virus on Lymphatic Tissue. II. Antigen-Stimulated Germfree and Conventional BALB/c Mice 1 (1970) (13)
- In Situ Expression of Tumor Immunity (1980) (13)
- Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT®-Tc), a totally human monoclonal antibody (1998) (13)
- Lymphatic Tissue Germinal Center Localization of 125I-labeled Heterologous and Isologous Macroglobulins (1967) (13)
- Immunological stimulation in situ: the acute and chronic inflammatory responses in the induction of tumor immunity. (1980) (13)
- The variable influence of host microflora and intercurrent infections on immunological competence and carcinogenesis. (1973) (12)
- Effects of poly(2'-O-methyladenylic acid) on susceptibility and autogenous immunity to RNA tumor virus oncogenesis in vivo. (1974) (12)
- Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression. (1972) (12)
- Tumor immunology and immunotherapy. (1979) (12)
- Glucan: attempts to demonstrate therapeutic activity against five syngeneic tumors in guinea pigs and mice. (1978) (12)
- A Comparative Study of the Immune Reaction in Germfree and Conventional Mice (1969) (12)
- New chelating agent for attaching indium-111 to monoclonal antibodies: in vitro and in vivo evaluation. (1992) (11)
- MORPHOLOGIC ASPECTS OF TUMOR CELL CYTOTOXICITY BY EFFECTOR CELLS OF THE MACROPHAGE-HISTIOCYTE COMPARTMENT: IN VITRO AND IN VIVO STUDIES IN BCG-MEDIATED TUMOR REGRESSION 1 (1976) (11)
- Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG). (1973) (11)
- Separation of guinea pig peripheral blood lymphocytes by discontinuous density gradient centrifugation using Ficoll-metrizoate. (1981) (11)
- Localization of Endogenous C-Type Virus in the Glomerular Basement Membrane of Aged AKR Mice (1973) (11)
- Immune Complexes and Human Cancer (1985) (11)
- The effect of antigen competition on both the primary and secondary immune capacity in mice. (1970) (11)
- Requirement for continuous antigenic stimulation in the development and differentiation of antibody-forming cells: effect of antigen dose. (1971) (10)
- Comparison of Existing Theories on the Function of Germinal Centers (1967) (10)
- Modulation of the Immune Response of Guinea Pigs by Repeated BCG Scarification 1 (1974) (10)
- More on the relevance of animal tumor models: immunogenicity of transplantable leukemias of recent origin in syngeneic strain 2 guinea pigs. (1984) (9)
- Evidence of functional microenvironments in lymphatic tissue response to antigen. (1971) (9)
- Time-dependent aggregation of reconstituted BCG vaccine. (1994) (9)
- Active Specific Immunotherapy of Human Colorectal Carcinoma with an Autologous Tumor Cell/Bacillus Calmette‐Guérin Vaccine (1993) (9)
- Histoproliferative effect of Rauscher leukemia virus on lymphatic tissue. 3. Alterations in the thymic-dependent area induced by the passenger lactic dehydrogenase virus. (1970) (9)
- Active specific immunotherapy of residual micrometastasis: the acute and chronic inflammatory response in induction of tumor immunity by BCG-tumor cell immunization. (1979) (8)
- Time Relationship of Injection of Actinomycin D and Antigen to the Immune Response.∗ (1965) (8)
- ACTINOMYCIN D EFFECT ON THE PRIMARY IMMUNE RESPONSE IN MICE: A HISTOLOGIC AND SEROLOGIC STUDY. (1965) (8)
- Morphology of experimental respiratory carcinogenesis : proceedings of a Biology Division, Oak Ridge National Laboratory, conference held in Gatlinburg, Tennessee, May 13-16, 1970 (1970) (8)
- EFFECTS OF CHRONIC EXPOSURE TO ARTIFICAL SMOG AND CHROMIUM OXIDE DUST ON THE INCIDENCE OF LUNG TUMORS IN MICE. (1970) (7)
- Cancer vaccines: are we there yet? (2012) (7)
- Characterization of the immune response to the major glycoprotein (gp 71) of Friend leukemia virus. I. Response in BALB/c mice. (1976) (7)
- Morphologic and Autoradiographic Studies of Spleen White Pulp Germinal Centers after Antigen Injection (1967) (7)
- Immunologic aspects of BCG-mediated regression of established tumors and metastases in guinea pigs. (1974) (7)
- Differential Effects of Two Strains of BCG on Transplantation Immunity to SV40-Induced Tumors in Hamsters 1 2 (1974) (7)
- Macrophages in tumor immunity. (1979) (6)
- Leukocyte migration inhibition of tumor antigen and purified protein derivative reactivity in guinea pigs sensitized to line 10 hepatocarcinoma and BCG. (1978) (6)
- Active (Patient Specific) Immunotherapy of Colon Cancer: A Transition from Preclinical Studies to Successful Clinical Trials (2014) (5)
- Autogenous immunity to endogenous RNA tumor virus: humoral immune response to virus envelope antigens. (1976) (5)
- ACTIVE SPECIFIC IMMUNOTHERAPY AS AN ADJUNCT TO THE TREATMENT OF METASTATIC SOLID TUMORS (1985) (5)
- Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor. (1977) (5)
- Randomized phase III trial of active specific immunotherapy (ASI) versus control in patients with Duke's B2, B3 or C colon cancer (1997) (5)
- Reduced immune potential of aged mice: significance of morphologic changes in lymphatic tissue. (1967) (4)
- AKR-MuLV-associated cell surface antigens (2005) (4)
- Labeling antisense deoxyoligonucleotide with Tc-99m and hybridization with c-myc oncogene MRNA in P388 leukemic cells (1994) (4)
- Active Specific Immunotherapy of Colorectal Cancer (1989) (4)
- Characterization of in vitro reactivity by BCG-treated guinea pigs to syngeneic line-10 hepatocarcinoma (2004) (4)
- Cell-mediated immune response of hamsters to alloantigen and tumor antigens of isologous and autochthonous origin during chemical carcinogenesis. (1974) (4)
- AUTOGENOUS IMMUNITY TO ENDOGENOUS RNA TUMOR VIRUS: VIRION AND VIRUS‐INDUCED CELL SURFACE ANTIGENS * (1976) (4)
- The efficacy of BCG-induced tumor immunity in guinea pigs with regional and systemic malignancy (1976) (4)
- MODIFICATION OF THE SPLEEN COLONY-FORMING ASSAY TO DEMONSTRATE IMMUNOLOGIC CROSS-REACTIVITY OF ANTIGENS COMMON TO TUMOR AND FETAL CELLS. (1972) (4)
- Specific Inhibition of Immunocompetence (1969) (3)
- Preclinical studies of indium-111-labeled IgM: a human monoclonal antibody for infection imaging. (1997) (3)
- Radioimmunolymphoscintigraphy in the preoperative staging of primary breast cancer. (1996) (3)
- Inhalation carcinogenesis : proceedings of a Biology Division, Oak Ridge National Laboratory, conference held in Gatlinburg, Tenn. October 8-11,1969 (1970) (3)
- Suppressive Effect of Immunization with Mouse Fetal Antigens on Growth of Cells Infected with Rauscher Leukemia Virus and on Plasma-Cell Tumors ( fetal neoantigens ) (3)
- Active specific immunotherapy as an adjunct to the treatment of metastatic solid tumors: present and future prospects. (1985) (3)
- The effect of a viral agent on lymphatic tissues. Abstr. (1967) (3)
- Active specific immunotherapy: Using tumor heterogeneity to successfully fight cancer (2014) (3)
- Antigenic heterogeneity of the guinea pig line 10 hepatocarcinoma. Implications for active specific immunotherapy (1982) (3)
- Development of a model of chronic lymphocytic leukemia in inbred strain 2 guinea pigs. (1983) (2)
- Human Monoclonal Antibodies: Application in Radioimmunotherapy (2018) (2)
- 20 – Human Monoclonal Antibodies: Concepts in Development and Application to Colon Cancer (1990) (2)
- Tumor-specific BCG therapy in colon cancer. (1990) (2)
- Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG (1979) (2)
- Fetal antigens in neoplasia (1973) (2)
- Human immune response to Rauscher leukemia virus. (1974) (2)
- Fundamentals of active specific immunotherapy of cancer using BCG-tumor cell vaccines. (1989) (2)
- Reaction of Lymphatic Tissue in Neoplastic Disease: Summary (1973) (2)
- Gallium-67 labelling of antisense deoxyoligonucleotide (GAASDON) probes and uptake in leukemic cells (P388) (1994) (2)
- Human Vaccines & Immunotherapeutics: News (2014) (2)
- Recent Developments and Perspectives on the Future of Human and Murine Monoclonal Antibodies in the Diagnosis and Treatment of Cancer (1990) (1)
- RADIATION-INDUCED IMMUNOSUPPRESSION: DEMONSTRATION OF ITS ROLE IN RADIATION LEUKEMOGENESIS IN THE INTACT RF MOUSE. (1972) (1)
- The balance of host immunocompetence in chemical carcinogenesis and "nonspecific" immunotherapy. (1975) (1)
- Contemporary Topics in Immunobiology (1974) (1)
- Immunobiology of oncogenic viruses (1977) (1)
- THREE-DIMENSIONAL DOSE RATE CALCULATION FROM BONE MARROW AUTORADIOGRAPHS FOR A PATIENT TREATED WITH Re-186 LABELED MONOCLONAL ANTIBODY (1994) (1)
- The effects of intravenous administration of Methanol Extraction Residue (MER) of tubercle bacilli in the dog (2004) (1)
- The mechanism of leukoregulin enhancement of target cell susceptibility to NK cell mediated cytotoxicity in humans. (1985) (1)
- IMMUNOTHERAPY FOR COLON CANCER. AUTHORS' REPLY (1999) (1)
- Pharmacokinetics of tumor localization and organ distribution of I-125 labeled human monoclonal antibodies in human colon tumor xenograft-bearing nude mice (1986) (1)
- INTERACTION OF RNA TUMOR VIRUSES AND THE IMMUNE SYSTEM: IMMUNE CAPACITY AND PATHOGENESIS. (1972) (1)
- Portrait of Dr Michael G. Hanna, Jr. A pioneer in active specific immunotherapy of cancer. (2014) (1)
- Histoproliferative effect of Rauscher leukemia virus on lymphatic tissue. IV. Lactic dehydrogenase virus and erythropoietin potentiation of the eythroid response. (1973) (1)
- Correspondence re: Janet H. Ransom, et al. Leukoregulin, a Direct-acting Anticancer Immunological Hormone That Is Distinct from Lymphotoxin and Interferon. Cancer Res., 45: 851–862, 1985—Reply (1987) (1)
- HUMAN ANTI-HUMAN ANTIBODY RESPONSE (HAHA) TO INJECTION OF 99mTc-, 131I-, 186Re-, 111In-, and 90Y-LABELED HUMAN MONOCLONAL ANTIBODY (1994) (0)
- In vivo immunology : histophysiology of the lymphoid system (1982) (0)
- The impact of genomic sequencing data in cancer immunotherapy (2013) (0)
- AUTOGENOUS IMMUNITY TO RNA TUMOR VIRUS activity (0)
- Preparation of Immunotherapeutic AutologousTumor Cell Vaccines from Solid Tumors 1 (2004) (0)
- The Fate of Antigens in Vivo (1971) (0)
- A backdoor into the castle: The clinical ramifications of immuno-editing driven by antigenic competition (2017) (0)
- A key to the backdoor into the castle: The clinical ramifications of immunoediting driven by antigenic competition (2017) (0)
- The primary immune response. (1965) (0)
- In Vivo Immunology (1982) (0)
- The practical influence of tumor genomic heterogeneity on active specific immunotherapy (2014) (0)
- Human immune response to active immunization with Rauscher leukemia virus (RLV) (1974) (0)
- Immunotherapy of cancer (1985) (0)
- A New Direct Method of Cell-Labeling in Whole Blood by Administration of 111In Labeled Anti-Sense Oligonucleotide Probe: Evaluation of Radiolabeled Probes for Noninvasive Imaging of Inflammation and Infection (1994) (0)
- Preparationof ImmunotherapeuticAutologousTumorCell Vaccinesfrom SolidTumors1 (1979) (0)
- Generationof TumorCell-reactiveHumanMonoclonalAntibodiesUsing PeripheralBloodLymphocytesfrom ActivelyImmunizedColorectal CarcinomaPatients (2006) (0)
- Evidence for an immune response to endogenous rna tumor in rfm mice. Abstr. (1972) (0)
- Immunotherap y for colon cancer (1999) (0)
- Lymphatic tissue localization of 125i-labeled heterologous and isologous macroglobulins. Abstr. (1966) (0)
- The provocative issue of tumor genomic heterogeneity in immunotherapy (2014) (0)
- Tumor virus envelope antigens and virus-induced cell surface antigens. (1975) (0)
- Studies of lymphatic tissue germinal centers during an immune re- action. Localization of 125i-labeled heterologous and isologous proteins. Abstr. (1966) (0)
- Contemporary Topics in Immunobiology (1974) (0)
- Tumor Immunology—Interaction between Lymphocytes, Antibodies and Neoplastic Cells: A Summary (1976) (0)
- STATISTICAL ANALYSIS OF AUTORADIOGRAPHIC AND HISTOLOGIC DATA. (1965) (0)
- Cell-mediated Immune Response of Hamsters to Alloantigen and Tumor Antigens of Isologous and Autochthonous Origin during Chemical Carcinogenesis1 (2006) (0)
- The characterization and efficacy of BCG mediated tumor activity in guinea pigs with regional and/or systemic malignancy (1976) (0)
- DEVELOPt1ENT AND GROHTH OF LYMPHOID GERmNAL CENTERS (1969) (0)
- CN3 IMMUNOTHERAPY WITH AUTOLOGOUS TUMOR CELL-BCG VACCINE (ONCOVAX®) IN PATIENTS WITH STAGE II COLON CANCER: MEDICAL AND ECONOMIC BENEFITS (2002) (0)
- Introduction: Non-Lymphoid Cells and Factors in Immune Reactions (1982) (0)
- Assessments of Active Specific Immunotherapy That May Provide a Pathway to Immunoprevention of Adenocarcinomas (2016) (0)
- The provocative issue of tumor genomic heterogeneity with respect to active and passive immunotherapy (2015) (0)
- Morphological and Functional Aspects of Active Specific Immunotherapy of Established Pulmonary Métastasesin Guinea Pigs1 (2006) (0)
- Immunotherapy for colon cancer (multiple letters) [2] (1999) (0)
- Vaccine therapy for colon cancer (1999) (0)
- AN AUTORADIOGRAPHIC AND HISTOLOGIC STUDY OF SPLEEN WHITE PULP GERMINAL CENTERS DURING EARLY INTERVALS OF THE PRIMARY IMMUNE RESPONSE. ORNL-3595. (1964) (0)
This paper list is powered by the following services:
